文献速递白血病MDS 与骨髓增殖性肿瘤

急性髓系白血病治疗后继发髓系肿瘤的分子特征

Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia.
PubMed 文献 · Leukemia · 2019-11-12

该研究对25例急性髓系白血病(AML)成功治疗后发生治疗相关髓系肿瘤(tMN)的患者进行全外显子测序,分析AML诊断、tMN诊断及配对缓解样本。发现76%(19/25)患者AML与tMN共享突变,主要涉及表观遗传修饰基因,提示存在共同祖先克隆。

要点

  • 76%(19/25)患者AML与tMN共享突变,支持共同祖先克隆假说。
  • 共享突变主要累及表观遗传修饰基因(21/32,66%)。
  • tAML突变数中位19个,高于tMDS的13个(p=0.05)。

核心结论

  • AML与tMN共享突变,提示存在共同祖先克隆。
  • 共享突变主要影响表观遗传修饰基因,与克隆性造血相关。

研究设计与样本

  • 对25例AML治疗后发生tMN的患者进行全外显子测序,分析AML诊断、tMN诊断(tMDS 13例,tAML 12例)及配对缓解样本。

主要发现

  • 共鉴定607个突变,影响504个不同基因,其中46个基因反复突变。
  • tAML突变数中位19个,tMDS中位13个(p=0.05)。
  • 19/25(76%)患者AML与tMN共享突变,涉及表观遗传修饰基因21/32(66%)、剪接因子6/32(19%)、染色质修饰基因3/32(9%)。
  • 缓解样本中10/22患者检出13个持续存在的突变,涉及DNMT3A(n=6)、TET2(n=5)、IDH1和SRSF2(各n=1)。
  • 核型分析:9/12 AML正常核型患者在tMN时出现异常;4例AML核型异常患者在tMN时为正常核型;另4例患者核型异常不相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Therapy-related myeloid neoplasms (tMN) following successful treatment of acute myeloid leukemia (AML) are rare and poorly characterized. To evaluate the presence of a common ancestral clone, we performed whole-exome sequencing of 25 patients at AML diagnosis, tMN diagnosis (tMDS: 13; tAML: 12), and matched remission samples, identifying 607 mutations affecting 504 different genes (46 recurrently mutated). Number of mutations was higher in tAML vs. tMDS cases (median 19 vs 13 mutations, p = 0.05). Focusing on 24 genes commonly mutated in hematological malignancies, 19/25 (76%) patients were found to share mutations between AML and tMN, mostly affecting epigenetic modifiers (21/32; 66%), splicing factors (6/32; 19%), and chromatin modifiers (3/32; 9%). Analysis of remission samples identified 13 persisting mutations in 10/22 patients, affecting DNMT3A (n = 6), TET2 (n = 5), IDH1 and SRSF2 (n = 1, each). Comparison of cytogenetics revealed that 9/12 patients with a normal karyotype (NK) in AML harbored aberrations in tMN, four aberrant AML cases presented with NK in tMN, four other patients showed unrelated cytogenetic aberrations. Our study provides novel insights into the pathogenesis of tMN, hypothesizing the presence of a common ancestral clone in AML and tMN. Mutations mostly affected epigenetic modifiers, which have previously been linked to clonal hematopoiesis.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hartmann L, Nadarajah N, Meggendorfer M, et al. Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia. Leukemia. 2019. PMID: 31719678. doi:10.1038/s41375-019-0633-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。